Related Experiment Video
Updated: Apr 7, 2026

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Non-Alcoholic Fatty Liver Disease (NAFLD) in children and adolescents with Prader-Willi Syndrome (PWS)
D Fintini1, E Inzaghi2,3, M Colajacomo4
1Autoimmune Endocrine Diseases Unit, Bambino Gesù Children's Hospital, Research Institute, Palidoro, Rome, Italy.
Insights
Patients with Prader-Willi syndrome (PWS) show a reduced risk of non-alcoholic fatty liver disease (NAFLD). This may be linked to improved insulin sensitivity and a better metabolic profile in PWS children.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Hepatology
Background:
- Prader-Willi syndrome (PWS) is a complex genetic disorder.
- Non-alcoholic fatty liver disease (NAFLD) is a growing health concern, particularly in children.
- Insulin resistance is a key factor in NAFLD development.
Purpose of the Study:
- To investigate the hypothesis that PWS patients have a lower risk of NAFLD due to enhanced insulin sensitivity.
- To compare the metabolic profiles and NAFLD prevalence between PWS patients and a control group.
Main Methods:
- A cohort study involving 21 PWS patients and 42 age-, sex-, and BMI-matched controls.
- Assessment of metabolic profiles, including glucose, lipids, and insulin resistance (HOMA-IR).
- Evaluation of NAFLD using validated ultrasound grading (G0-G3) and body composition analysis.
Main Results:
- PWS patients exhibited significantly better metabolic profiles: lower waist circumference, fasting glucose, HOMA-IR, cholesterol, transaminases, and trunk fat.
- NAFLD G1 stage was more frequent in PWS subjects (P<0.05), while G2 stage was more frequent in controls (P<0.05).
- NAFLD grading correlated with body composition in PWS, independent of sex and GH treatment.
Conclusions:
- This study suggests a reduced risk of NAFLD in children with Prader-Willi syndrome.
- Improved insulin sensitivity and metabolic health may contribute to this protective effect in PWS.
- Further research is warranted to elucidate the mechanisms underlying NAFLD risk in PWS.
Abstract:
We tested the hypothesis that patients with Prader-Willi syndrome (PWS) may be at lower risk of developing non-alcoholic fatty liver disease (NAFLD) because of a higher insulin sensitivity. Twenty-one PWS patients and 42 control subjects closely similar for age, gender, pubertal stage and body mass index (CNT), were studied. Metabolic profile and body composition were assessed. NAFLD was established by a validated method of US grading (range from G0 to G3). PWS patients showed a significantly better metabolic profile (lower waist circumference, fasting glucose levels, HOMA-IR, cholesterol, transaminase levels and trunk fat mass/fat mass ratio). Furthermore, NAFLD G1stage was significantly more frequent in PWS subjects (P < 0.05), whereas G2 stage was significantly more frequent in control patients (P < 0.05). NAFLD grading seems to correlate with body composition in PWS, also after adjustment for sex and GH treatment. To our knowledge, this is the first report suggesting a reduced risk of NAFLD in PWS children.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
Related Concept Videos
Inborn Errors of Metabolism
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):